Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 More on aprepitant for erlotinib-induced pruritus.

Literature DB >> 21288112

Review 1. Rosacea: The cytokine and chemokine network.

Authors: Peter Arne Gerber; Bettina Alexandra Buhren; Martin Steinhoff; Bernhard Homey
Journal: J Investig Dermatol Symp Proc Date: 2011-12

2. Mechanisms of skin aging induced by EGFR inhibitors.

Authors: Peter Arne Gerber; Bettina Alexandra Buhren; Holger Schrumpf; Peter Hevezi; Edwin Bölke; Dennis Sohn; Reiner U Jänicke; Viswanath Reddy Belum; Caroline Robert; Mario E Lacouture; Bernhard Homey
Journal: Support Care Cancer Date: 2016-05-10 Impact factor: 3.603

3. Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: a pooled analysis.

Authors: Viswanath Reddy Belum; Courtney Washington; Christine A Pratilas; Vincent Sibaud; Franck Boralevi; Mario E Lacouture
Journal: Pediatr Blood Cancer Date: 2015-02-12 Impact factor: 3.167

4. Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients.

Authors: Peter Arne Gerber; Stephan Meller; Tatiana Eames; Bettina Alexandra Buhren; Holger Schrumpf; Sonja Hetzer; Laura Maximiliane Ehmann; Wilfried Budach; Edwin Bölke; Christiane Matuschek; Andreas Wollenberg; Bernhard Homey
Journal: Eur J Med Res Date: 2012-02-23 Impact factor: 2.175

Review 5. [Cutaneous side effects of targeted cancer drugs].

Authors: J Below; B Homey; P A Gerber
Journal: Hautarzt Date: 2017-01 Impact factor: 0.751

Review 6. [Drug reactions caused by chemotherapy agents].

Authors: L M Ehmann; H Schrumpf; P A Gerber; B Homey
Journal: Hautarzt Date: 2014-05 Impact factor: 0.751

7. Neurokinin 1 Receptor Antagonists for Pruritus.

Authors: Majid Alam; Joerg Buddenkotte; Fareed Ahmad; Martin Steinhoff
Journal: Drugs Date: 2021-03-06 Impact factor: 9.546

8. Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial.

Authors: Bruno Vincenzi; Mike Trower; Ajay Duggal; Pamela Guglielmini; Peter Harris; David Jackson; Mario E Lacouture; Emiliangelo Ratti; Giuseppe Tonini; Andrew Wood; Sonja Ständer
Journal: BMJ Open Date: 2020-02-06 Impact factor: 2.692

Review 9. Dermatologic conditions in women receiving systemic cancer therapy.

Authors: Michelle N Ferreira; Julie Y Ramseier; Jonathan S Leventhal
Journal: Int J Womens Dermatol Date: 2019-11-07

10. Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists.

Authors: Shawn G Kwatra; Emily Boozalis; Amy H Huang; Cory Nanni; Raveena Khanna; Kyle A Williams; Yevgeniy R Semenov; Callie M Roberts; Robert F Burns; Madison Krischak; Madan M Kwatra
Journal: Medicines (Basel) Date: 2019-12-09